Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for HUTCHMED (China) Limited Sponsored ADR (HCM : NSDQ)

• Company Description    HUTCHMED Limited is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. HUTCHMED Limited, formerly known as HUTCHMED (China) Limited, is based in HONG KONG. Number of Employees: 1,796

• Price / Volume Information    Yesterday's Closing Price: $14.36 Daily Weekly Monthly 20 Day Moving Average: 52,029 shares Shares Outstanding: 174.47 (millions) Market Capitalization: $2,505.35 (millions) Beta: 0.18 52 Week High: $16.33 52 Week Low: $9.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.31% 4.40% 12 Week 33.33% 30.08% Year To Date 7.73% -4.31%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 48TH FLOOR CHEUNG KONG CENTER 2 QUEEN`S ROAD CENTRAL - HONG KONG,K3 00000 HKG ph: 852-2121-3888 fax: 852-2128-1778 ir@hutch-med.com http://www.hutch-med.com

• General Corporate Information    Officers Weiguo SU - Chief Executive Officer Dan ELDAR - Chairman Lorenso CHIU - Chief Financial Officer Ling YANG - Non-executive Director TAN Shao Weng, Daniel - Non-executive Director Peer Information HUTCHMED (China) Limited Sponsored ADR (CORR.) HUTCHMED (China) Limited Sponsored ADR (RSPI) HUTCHMED (China) Limited Sponsored ADR (CGXP) HUTCHMED (China) Limited Sponsored ADR (BGEN) HUTCHMED (China) Limited Sponsored ADR (GTBP) HUTCHMED (China) Limited Sponsored ADR (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 44842L103 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 174.47 Most Recent Split Date: (:1) Beta: 0.18 Market Capitalization: $2,505.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.23 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: 63.35 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.97 Price/Cash Flow: 5.33 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - - 03/31/26 - - ROA 09/30/26 - - 06/30/26 - - 03/31/26 - - Current Ratio 09/30/26 - - 06/30/26 - 5.64 03/31/26 - - Quick Ratio 09/30/26 - - 06/30/26 - 5.50 03/31/26 - - Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 7.31 03/31/26 - - Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.06 03/31/26 - - Debt-to-Capital 09/30/26 - - 06/30/26 - 5.35 03/31/26 - -

Powered by Zacks Investment Research ©